Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

On the proposed definition of metabolic associated fatty liver disease

(2021) Vincent Wai-Sun Wong et al.   Clinical Gastroenterology and Hepatology

MAFLD and cardiovascular events: what does the evidence show?

(2021) Jacob George et al.   Clinical Gastroenterology and Hepatology

Once-Weekly Semaglutide in Adults with Overweight or Obesity

(2021) John P.H. Wilding et al.   NEW ENGLAND JOURNAL OF MEDICINE

Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease

(2021) Soo Lim et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality

(2020) Eric R. Yoo et al.   LIVER INTERNATIONAL

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality

(2020) Donghee Kim et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

From NAFLD to MAFLD: Implications of a premature change in terminology

(2020) Zobair M Younossi et al.   HEPATOLOGY

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

(2020) Philip N. Newsome et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association

(2019) Andrew A. Li et al.   Hepatobiliary Surgery and Nutrition

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

(2019) Myriam Alexander et al.   BMJ-British Medical Journal

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

(2018) Donghee Kim et al.   Clinics in Liver Disease

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

(2017) Chris Estes et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

(2012) Donghee Kim et al.   HEPATOLOGY

Association of leisure-time physical activity with cognition by apolipoprotein-E genotype in persons aged 60 years and over: the National Health and Nutrition Examination Survey (NHANES-III)

(2012) Thomas Obisesan et al.   Clinical Interventions in Aging

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

(2010) P. Loria et al.   DIGESTIVE AND LIVER DISEASE

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology